1. Home
  2. GOSS vs TCI Comparison

GOSS vs TCI Comparison

Compare GOSS & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • TCI
  • Stock Information
  • Founded
  • GOSS 2015
  • TCI 1983
  • Country
  • GOSS United States
  • TCI United States
  • Employees
  • GOSS N/A
  • TCI N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • GOSS Health Care
  • TCI Finance
  • Exchange
  • GOSS Nasdaq
  • TCI Nasdaq
  • Market Cap
  • GOSS 501.2M
  • TCI 403.2M
  • IPO Year
  • GOSS 2019
  • TCI N/A
  • Fundamental
  • Price
  • GOSS $3.17
  • TCI $45.50
  • Analyst Decision
  • GOSS Strong Buy
  • TCI
  • Analyst Count
  • GOSS 6
  • TCI 0
  • Target Price
  • GOSS $8.60
  • TCI N/A
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • TCI 1.2K
  • Earning Date
  • GOSS 11-05-2025
  • TCI 11-06-2025
  • Dividend Yield
  • GOSS N/A
  • TCI N/A
  • EPS Growth
  • GOSS N/A
  • TCI 75.87
  • EPS
  • GOSS N/A
  • TCI 0.65
  • Revenue
  • GOSS $44,051,000.00
  • TCI $48,675,000.00
  • Revenue This Year
  • GOSS N/A
  • TCI N/A
  • Revenue Next Year
  • GOSS $16.11
  • TCI N/A
  • P/E Ratio
  • GOSS N/A
  • TCI $70.75
  • Revenue Growth
  • GOSS N/A
  • TCI N/A
  • 52 Week Low
  • GOSS $0.66
  • TCI $25.50
  • 52 Week High
  • GOSS $3.60
  • TCI $48.00
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.68
  • TCI 52.08
  • Support Level
  • GOSS $2.42
  • TCI $43.00
  • Resistance Level
  • GOSS $2.71
  • TCI $46.00
  • Average True Range (ATR)
  • GOSS 0.19
  • TCI 0.81
  • MACD
  • GOSS 0.09
  • TCI 0.07
  • Stochastic Oscillator
  • GOSS 96.48
  • TCI 51.55

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: